Vascular effects of calcium channel antagonists: New evidence

Drugs

Volumn 65, Issue SUPPL. 2, 2005, Pages 1-10

  Richard, Sylvain ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; BENZYDAMINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL T TYPE; DILTIAZEM; EFONIDIPINE; MANIDIPINE; NILVADIPINE; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ARTERIOLE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CORONARY BLOOD VESSEL; GLOMERULUS; HEART MUSCLE CELL; HUMAN; NONHUMAN; RENOVASCULAR HYPERTENSION; REVIEW; SIDE EFFECT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, T-TYPE; CARDIOVASCULAR DISEASES; DIHYDROPYRIDINES; HUMANS; HYPERTENSION, RENAL; ION CHANNEL GATING; KIDNEY GLOMERULUS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RENAL CIRCULATION;

EID: 26944490672     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200565010-00001     Document Type: Review

References (53)

1. McKeage K, Scott LJ. Manidipine: a review of its use in the management of hypertension. Drugs 2004; 64: 1923-40
2. Ringer S. A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol 1883; 4: 29-42
3. Yamakage M, Namiki A. Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review. Can J Anaesth 2002; 49: 151-64
4. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-6
5. 2+ channels. Annu Rev Cell Dev Biol 2000; 16: 521-55
6. Nargeot J, Lory P, Richard S. Molecular basis of the diversity of calcium channels in cardiovascular tissues. Eur Heart J 1997; 18 suppl. A: A15-26
7. Triggle DJ. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 2003; 23: 293-303
8. van Zwieten PA. The pharmacological properties of lipophilic calcium antagonists. Blood Press Suppl 1998; 2: 5-9
9. Perez-Reyes E. Molecular characterization of a novel family of low voltage-activated, T-type, calcium channels. J Bioenerg Biomembr 1998; 30: 313-8
10. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 2003; 83: 117-61
11. Perez-Reyes E. Paradoxical role of t-type calcium channels in coronary smooth muscle. Mol Interv 2004; 4: 16-8
12. 2+ in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 1998; 508: 199-209
13. Nelson MT, Patlak JB, Worley JF, et al. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990; 259: C3-18
14. 2+ stores in single smooth muscle cells from rat cerebral arteries. J Physiol 1997; 501: 497-508
15. v1.2 for blood pressure regulation. Embo J 2003; 22: 6027-34
16. Wilde DW, Furspan PB, Szocik JF. Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension 1994; 24: 739-46
17. Harder DR, Smeda J, Lombard J. Enhanced myogenic depolarization in hypertensive cerebral arterial muscle. Circ Res 1985; 57: 319-22
18. 2+ channels: is membrane depolarization the signal? Circ Res 2004; 94: e97-104
19. 2+ entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol Heart Circ Physiol 2001; 281: H2559-67
20. Richard S, Nargeot J. T-type calcium currents in vascular smooth muscle cells: a role in cellular proliferation? In: Tsien R, Clozel J, Nargeot J, editors. Low-voltage-activated T-type calcium channels. Proceedings of the International Electrophysiology Meeting. Montpellier, France, 21-22 October 1996. Chester (UK): Adis International; 1998
21. Quignard JF, Frapier JM, Harricane MC, et al. Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide. J Clin Invest 1997; 99: 185-93
22. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 1996; 79: 14-9
23. Neveu D, Quignard JF, Fernandez A, et al. Differential beta-adrenergic regulation and phenotypic modulation of voltage-gated calcium currents in rat aortic myocytes. J Physiol 1994; 479: 171-82
24. Gordienko DV, Clausen C, Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol 1994; 266: F325-41
25. 2+ channels. Science 2003; 302: 1416-8
26. 2+-sensitive ion channels. Cell Calcium 2003; 34: 211-29
27. VanBavel E, Sorop O, Andreasen D, et al. Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2002; 283: H2239-43
28. Feng MG, Li M, Navar LG. T-type calcium channels in the regulation of afferent and efferent arterioles in rats. Am J Physiol Renal Physiol 2004; 286: F331-7
29. Hansen PB, Jensen BL, Andreasen D, et al. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 2001; 89: 630-8
30. Ozawa Y, Hayashi K, Nagahama T, et al. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hypertension 2001; 38: 343-7
31. Jensen LJ, Salomonsson M, Jensen BL, et al. Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels. Br J Pharmacol 2004; 142: 709-18
32. 2+ channels. Am J Physiol Heart Circ Physiol 2001; 280: H582-90
33. 2+Channel, and It is functionally important in renal afferent arterioles. Circ Res 2000; 87: 896-902
34. Salomonsson M, Sorensen CM, Arendshorst WJ, et al. Calcium handling in afferent arterioles. Acta Physiol Scand 2004; 181: 421-9
35. Bossert F, Vater W. Dihydropyridines, a new group of strongly effective coronary therapeutic agents [in German]. Naturwissenschaften 1971; 58: 578
36. ++ ions for the bioelectrical and mechanical activity of smooth muscle [in German]. Arzneimittelforschung 1972; 22:334-44
37. Grun G, Fleckenstein A. Calcium-antagonism, a new principle in coronary vasodilation [in Italian]. Minerva Med 1975; 66: 1838-45
38. Sun J, Triggle DJ. Calcium channel antagonists: cardiovascular selectivity of action. J Pharmacol Exp Ther 1995; 274: 419-26
39. 2+ channels. Trends Pharmacol Sci 1998; 19: 108-15
40. 2+ channel currents with distinct electrophysiological and pharmacological properties in cultured rat aortic myocytes. Pflugers Arch 1993; 424: 45-53
41. Hayashi K, Ozawa Y, Fujiwara K, et al. Role of actions of calcium antagonists on efferent arterioles - with special references to glomerular hypertension. Am J Nephrol 2003; 23: 229-44
42. 2+ channels. Cardiovasc Drug Rev 2002; 20: 81-92
43. Honda M, Hayashi K, Matsuda H, et al. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo. J Hypertens 2001; 19: 2031-7
44. Hayashi K, Nagahama T, Oka K, et al. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 1996; 19: 31-6
45. Takabatake T, Ohta H, Sasaki T, et al. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients. Eur J Clin Pharmacol 1993; 45: 321-5
46. Yue W, Kimura S, Fujisawa Y, et al. Benidipine dilates both pre- and post-glomerular arteriole in the canine kidney. Hypertens Res 2001; 24: 429-36
47. Del Vecchio L, Pozzi M, Salvetti A, et al. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. J Nephrol 2004; 17: 261-9
48. Arima S, Ito S, Omata K, et al. Diverse effects of calcium antagonists on glomerular hemodynamics. Kidney Int Suppl 1996; 55: S132-4
49. 2+ channels. Br J Pharmacol 2004; 143: 1050-7
50. 2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 2005; 45: 241-6
51. 2+ exchanger in rat and human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 458-63
52. 2+ entry. Circ Res 2000; 87: 551-7
53. Takenaka T, Suzuki H, Okada H, et al. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int 2002; 62: 558-65